Chikungunya Virus: What It Is, How It Spreads, and Why It Matters
- MedReport Foundation
- 7 hours ago
- 3 min read
By: Pawan Krishna Murti
Chikungunya is a disease caused by the chikungunya virus (CHIKV), which is spread to humans through the bite of infected mosquitoes, mainly Aedes aegypti and Aedes albopictus. These are the same mosquitoes that transmit dengue and Zika viruses.
The disease was first identified in Tanzania in 1952. The name “chikungunya” comes from a local word meaning “bent over,” referring to the severe joint pain that often forces people into a stooped posture.
How the Illness Feels
Most people infected with chikungunya develop symptoms within 3–7 days after a mosquito bite. The illness usually includes:
● Sudden high fever
● Severe joint pain (often the most intense symptom)
● Muscle pain
● Headache
● Rash
● Fatigue
While most patients recover within a week or two, the joint pain can sometimes last for months or even years. A small number of people may develop more serious illness involving:
● Brain inflammation (encephalitis)
● Meningitis
● Nerve damage conditions such as Guillain–Barré syndrome
Death is rare, but severe cases do occur, especially in older adults or people with other health problems.
How the Virus Spreads Around the World
Chikungunya originally circulated in Africa and Asia but has now spread worldwide, including the Americas and parts of Europe.
Major outbreaks occurred in:
● Indian Ocean islands (2005–2006, especially Réunion Island)
● India and Southeast Asia
● Caribbean and South America (after 2013)
● Some parts of Europe (imported and local outbreaks)
The virus has evolved over time, and certain genetic changes have helped it spread more efficiently through mosquitoes, especially Aedes albopictus, which can survive in more temperate regions. Climate change, urbanization, and global travel are helping mosquitoes and the virus expand into new areas.
What the Virus Does in the Body
After entering the body, the virus spreads in the blood and mainly affects:
● Joints
● Muscles
● Skin
● Sometimes the nervous system
The severe joint pain happens because the virus triggers an intense immune response, causing inflammation in joints and surrounding tissues.
In some people, the immune system may continue to stay activated even after the virus is gone, which may explain long-lasting pain.
Why Some People Get More Severe Disease
Severe or long-lasting chikungunya is more likely in:
● Older adults
● Women
● People with strong early inflammation
● Individuals with weaker or altered immune responses
● Genetics may also play a role in how the body responds to infection.
Brain and Nerve Complications
Although chikungunya is not mainly a brain-infecting virus, in rare cases, it can affect the nervous system.
Reported complications include:
● Brain inflammation
● Spinal cord inflammation
● Nerve disorders like Guillain–Barré syndrome
These cases are uncommon but can be serious, especially during large outbreaks.
Treatment
There is currently:
● No specific antiviral treatment
● No widely available vaccine yet
Treatment focuses on:
● Pain relief (paracetamol, anti-inflammatory drugs)
● Rest and hydration
● Managing complications if they occur
● Vaccines Under Development
Several vaccine types are being tested, including:
● Live weakened virus vaccines
● Inactivated (killed) virus vaccines
● Virus-like particle vaccines
● mRNA vaccines
● Viral vector vaccines
Some have reached late-stage clinical trials and show promising immune protection, but none are yet widely available to the public.
Why Chikungunya Is a Growing Concern
Chikungunya is becoming more important globally because:
● Mosquitoes that carry it are spreading to new regions
● Climate change is expanding mosquito habitats
● Urban populations provide ideal conditions for outbreaks
● No approved vaccine is widely available yet
● It can cause long-term disabling joint pain
Key Takeaway
Chikungunya is usually not fatal, but it can cause severe and sometimes long-lasting joint pain, and in rare cases, serious neurological complications. Because mosquitoes that spread the virus are expanding globally, chikungunya remains an important emerging public health threat.
References
1. Cavalcanti TYVL, Pereira MR, de Paula SO, Franca RFO. A review on chikungunya virus epidemiology,
pathogenesis, and current vaccine development. Viruses. 2022 May 5;14(5):969. doi:10.3390/v14050969.
PMID: 35632709; PMCID: PMC9147731. Available from:
2. World Health Organization. Chikungunya. Available from:
3. Institut Pasteur. Chikungunya. Available
4. Zhao T, Chen T, Zhang J, Li C, Qin C. Chikungunya virus: Current situation and future challenges. Biosaf
Health. 2025;7(6):348-356. doi:10.1016/j.bsheal.2025.10.001. Available from:
5. Dos Santos GR, Jawed F, Mukandavire C, Deol A, Scarponi D, Mboera LEG, et al. Global burden of
chikungunya virus infections and the potential benefit of vaccination campaigns. Nat Med.
2025;31:2342-2349. doi:10.1038/s41591-025-03702-3. Available from:
Assessed and Endorsed by the MedReport Medical Review Board
